SpringWorks Therapeutics, Inc. (SWTX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 10:25AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 3.18B |
| Enterprise Value | 2.71B |
| Trailing P/E | 21.09 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 497.39 |
| Price/Book (mrq) | 5.08 |
| Enterprise Value/Revenue | 496.88 |
| Enterprise Value/EBITDA | -7.93 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.82 |
| 52-Week Change 3 | 78.41% |
| S&P500 52-Week Change 3 | 23.06% |
| 52 Week High 3 | 53.92 |
| 52 Week Low 3 | 18.00 |
| 50-Day Moving Average 3 | 47.73 |
| 200-Day Moving Average 3 | 34.06 |
Share Statistics
| Avg Vol (3 month) 3 | 1.13M |
| Avg Vol (10 day) 3 | 749.6k |
| Shares Outstanding 5 | 74.06M |
| Implied Shares Outstanding 6 | 74.06M |
| Float 8 | 68.05M |
| % Held by Insiders 1 | 2.24% |
| % Held by Institutions 1 | 107.56% |
| Shares Short (Mar 28, 2024) 4 | 10.66M |
| Short Ratio (Mar 28, 2024) 4 | 10.09 |
| Short % of Float (Mar 28, 2024) 4 | 17.43% |
| Short % of Shares Outstanding (Mar 28, 2024) 4 | 14.39% |
| Shares Short (prior month Feb 29, 2024) 4 | 11.13M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -1,807.66% |
Management Effectiveness
| Return on Assets (ttm) | -31.62% |
| Return on Equity (ttm) | -54.90% |
Income Statement
| Revenue (ttm) | 5.45M |
| Revenue Per Share (ttm) | 0.09 |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -341.35M |
| Net Income Avi to Common (ttm) | -325.1M |
| Diluted EPS (ttm) | -5.15 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 479.2M |
| Total Cash Per Share (mrq) | 6.5 |
| Total Debt (mrq) | 7.06M |
| Total Debt/Equity (mrq) | 1.13% |
| Current Ratio (mrq) | 6.41 |
| Book Value Per Share (mrq) | 8.53 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -222.8M |
| Levered Free Cash Flow (ttm) | -113.19M |
© 2024 Yahoo. All rights reserved.